drugset / Trial / NCT03221231

N-acetylcysteine for the Treatment of Cannabis Dependence: Working Mechanisms

NCT03221231

Phase 4 Unknown 75 enrolled University Hospital Brussels
RandomizedParallel-groupDouble-blindBasic science

Summary

This study investigates the effects of repeated NAC administration on glutamate concentrations in the anterior cingulate cortex (ACC), on neurocognitive functioning, and on neuro-inflammatory parameters in adult cannabis-dependent individuals.

Timeline

Start
2016-05-15
Primary completion
2022-02-01
Completion
2023-02-01

Drugs

EvaluationDrugModalityDoseRoute
Subject N-acetylcysteine Small molecule 1200 mg

Indications